AZOLINE Trademark
Trademark Overview
On Thursday, September 5, 2002, a trademark application was filed for AZOLINE with the United States Patent and Trademark Office. The USPTO has given the AZOLINE trademark a serial number of 78160860. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 24, 2003. This trademark is owned by Barrier Therapeutics, Inc.. The AZOLINE trademark is filed in the Pharmaceutical Products category with the following description:
Anti-fungal pharmaceutical preparation
General Information
Serial Number | 78160860 |
Word Mark | AZOLINE |
Filing Date | Thursday, September 5, 2002 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, September 24, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Anti-fungal pharmaceutical preparation |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 18, 2002 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Barrier Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Princeton, NJ 08540 |
Trademark Events
Event Date | Event Description |
Wednesday, September 24, 2003 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Sunday, February 2, 2003 | NON-FINAL ACTION E-MAILED |
Friday, January 24, 2003 | ASSIGNED TO EXAMINER |